(Q88792022)
Statements
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial (English)
Charlotte Suppli Ulrik
Latifa Chachi
J Mark FitzGerald
Vibeke Backer
Ronald Olivenstein
Ingrid L Titlestad
Timothy Harrison
Dave Singh
Rekha Chaudhuri
Brian Leaker
Lorcan McGarvey
Millie Wang
Martin Braddock
Lars H Nordenmark
David Cohen
Himanshu Parikh
Gene Colice
MESOS study investigators